Third follow-up: Whole-body CT showed no signs of recurrence or metastasis. Tumor marker levels: AFP, 7.2 ng/mL; CEA, 5.3 ng/mL; CA19-9, 22.6 U/mL; CA72-4, 9.12 U/mL. This evidence concerns the gene CEACAM5 and neoplasm.